AU Patent

AU2012215440B2 — Isoxazoline derivatives for controlling invertebrate pests

Assigned to Elanco Tiergesundheit AG · Expires 2015-08-27 · 11y expired

What this patent protects

The invention relates to new isoxazoline compounds of formula (I), wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the cont…

USPTO Abstract

The invention relates to new isoxazoline compounds of formula (I), wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in particular ectoparasites, in and on warmblooded animals.

Drugs covered by this patent

Patent Metadata

Patent number
AU2012215440B2
Jurisdiction
AU
Classification
—
Expires
2015-08-27
Drug substance claim
No
Drug product claim
No
Assignee
Elanco Tiergesundheit AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.